Anti-Clotting Drug More Critical for Female Stroke Victims: Study

(HealthScout) UPDATED 2010-03-01

A new study published in the journal Neurology suggests that women who aren't given the anti-clotting medication tissue plasminogen activator (tPA) fare worse than men who don't receive the drug. Read full story >

See all Heart Disease News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2010. The HealthCentral Network, Inc. All rights reserved.

Anti-Clotting Drug More Critical for Female Stroke Victims: Study

People who read this also read...

What the community is saying...

Good heart foods

Pearlene